Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome-Reference-Cited by-同舟云学术

Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome

Published:2023-05-30 Issue:1 Volume:40 Page:
ISSN:0265-6736
Container-title:International Journal of Hyperthermia
language:en
Short-container-title:International Journal of Hyperthermia

Author:

Kim Jae Hyun¹,Lee Jae Young¹,Yu Su Jong²,Lee Dong Ho¹,Joo Ijin¹,Yoon Jung-Hwan²,Kim Yoon Jun²,Yoon Jeong Hee¹,Lee Jeong Min¹³

Affiliation:

1. Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea

2. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea

3. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea

Publisher

Informa UK Limited

Subject

Cancer Research,Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02656736.2023.2213424

Reference34 articles.

1. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations

2. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

3. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy

5. Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma;Cancers;2024-03-03

2. Application and evaluation of hydrodissection in microwave ablation of liver tumours in difficult locations;Frontiers in Oncology;2023-11-16